skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,043  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Cardiac & Cardiovascular Systems remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pleiotropic Effects of Statins on the Cardiovascular System
Pleiotropic Effects of Statins on the Cardiovascular System
Material Type:
Article 		Add to My Research

Pleiotropic Effects of Statins on the Cardiovascular System

Circulation research, 2017-01, Vol.120 (1), p.229-243 [Peer Reviewed Journal]

2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Jan 6, 2017 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.308537 ;PMID: 28057795

Full text available

Citations Cited by
2
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Material Type:
Article 		Add to My Research

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation (New York, N.Y.), 2018-01, Vol.137 (4), p.338-350 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.032235 ;PMID: 29133605

Full text available

Citations Cited by
3
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Material Type:
Article 		Add to My Research

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Circulation research, 2016-02, Vol.118 (4), p.547-563 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306249 ;PMID: 26892957

Full text available

Citations Cited by
4
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Material Type:
Article 		Add to My Research

Quantifying Importance of Major Risk Factors for Coronary Heart Disease

Circulation (New York, N.Y.), 2019-03, Vol.139 (13), p.1603-1611 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.031855 ;PMID: 30586759

Full text available

Citations Cited by
5
The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
Material Type:
Article 		Add to My Research

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

European heart journal, 2016-02, Vol.37 (6), p.536-545 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehv563 ;PMID: 26578202

Full text available

Citations Cited by
6
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial
Material Type:
Article 		Add to My Research

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial

Circulation (New York, N.Y.), 2018-05, Vol.137 (19), p.1997-2009 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.032615 ;PMID: 29735587

Full text available

Citations Cited by
7
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis
Material Type:
Article 		Add to My Research

Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis

Journal of the American College of Cardiology, 2012-12, Vol.60 (25), p.2631-2639 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.09.017 ;PMID: 23083789 ;CODEN: JACCDI

Full text available

Citations Cited by
8
PCSK9 inhibitors: clinical evidence and implementation
PCSK9 inhibitors: clinical evidence and implementation
Material Type:
Article 		Add to My Research

PCSK9 inhibitors: clinical evidence and implementation

Nature reviews cardiology, 2019-03, Vol.16 (3), p.155-165 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2019 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-018-0107-8 ;PMID: 30420622

Full text available

Citations Cited by
9
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Material Type:
Article 		Add to My Research

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up

Circulation (New York, N.Y.), 2017-11, Vol.136 (20), p.1878-1891 [Peer Reviewed Journal]

2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.027966 ;PMID: 28877913

Full text available

Citations Cited by
10
Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia
Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia
Material Type:
Article 		Add to My Research

Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia

European heart journal, 2017-05, Vol.38 (20), p.1573-1579 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehx004 ;PMID: 28159968

Full text available

Citations Cited by
11
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Material Type:
Article 		Add to My Research

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Journal of the American College of Cardiology, 2021-08, Vol.78 (5), p.421-433 [Peer Reviewed Journal]

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.102 ;PMID: 34325831

Full text available

Citations Cited by
12
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Material Type:
Article 		Add to My Research

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

Nature reviews cardiology, 2011-04, Vol.8 (4), p.222-232 [Peer Reviewed Journal]

2011 Macmillan Publishers Limited. All rights reserved ;COPYRIGHT 2011 Nature Publishing Group ;COPYRIGHT 2011 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2011 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/nrcardio.2010.222 ;PMID: 21304474

Full text available

Citations Cited by
13
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Material Type:
Article 		Add to My Research

Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models

Circulation (New York, N.Y.), 2023-01, Vol.147 (3), p.242-253 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.062132 ;PMID: 36314243

Full text available

Citations Cited by
14
Prognostic value of PCSK9 levels in patients with acute coronary syndromes
Prognostic value of PCSK9 levels in patients with acute coronary syndromes
Material Type:
Article 		Add to My Research

Prognostic value of PCSK9 levels in patients with acute coronary syndromes

European heart journal, 2016-02, Vol.37 (6), p.546-553 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehv637 ;PMID: 26655339

Full text available

Citations Cited by
15
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Material Type:
Article 		Add to My Research

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

European heart journal, 2020-06, Vol.41 (24), p.2313-2330 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz962 ;PMID: 32052833

Full text available

Citations Cited by
16
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial
Material Type:
Article 		Add to My Research

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361 [Peer Reviewed Journal]

Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.10.077 ;PMID: 26821621

Full text available

Citations Cited by
17
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Material Type:
Article 		Add to My Research

Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia

Circulation (New York, N.Y.), 2013-11, Vol.128 (19), p.2113-2120 [Peer Reviewed Journal]

2013 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2014 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.004678 ;PMID: 24014831 ;CODEN: CIRCAZ

Full text available

Citations Cited by
18
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Material Type:
Article 		Add to My Research

Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis

Circulation research, 2016-02, Vol.118 (4), p.579-585 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306398 ;PMID: 26892959

Full text available

Citations Cited by
19
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control
Material Type:
Article 		Add to My Research

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

Circulation (New York, N.Y.), 2016-12, Vol.134 (24), p.1931-1943 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 The Authors. ;2016 The Authors. 2016 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.024604 ;PMID: 27777279

Full text available

Citations Cited by
20
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels: Results From 2 Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1 Studies in Healthy Volunteers and Hypercholesterolemic Subjects on Statins
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels: Results From 2 Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1 Studies in Healthy Volunteers and Hypercholesterolemic Subjects on Statins
Material Type:
Article 		Add to My Research

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels: Results From 2 Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1 Studies in Healthy Volunteers and Hypercholesterolemic Subjects on Statins

Journal of the American College of Cardiology, 2012-11, Vol.60 (19), p.1888-1898 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.08.986 ;PMID: 23083772 ;CODEN: JACCDI

Full text available

Citations Cited by

Results 1 - 20 of 3,043  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,830)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1989  (181)
  2. 1989 To 1996  (385)
  3. 1997 To 2004  (666)
  4. 2005 To 2013  (709)
  5. After 2013  (1,102)
  6. More options open sub menu

Language 

  1. English  (3,014)
  2. Japanese  (524)
  3. Portuguese  (42)
  4. German  (19)
  5. Turkish  (19)
  6. Russian  (4)
  7. Norwegian  (3)
  8. Italian  (2)
  9. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait